These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension. Coleman AL; Lerner F; Bernstein P; Whitcup SM Ophthalmology; 2003 Dec; 110(12):2362-8. PubMed ID: 14644719 [TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines. Stewart WC; Konstas AG; Nelson LA; Kruft B Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886 [TBL] [Abstract][Full Text] [Related]
4. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy. Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study. Ozturk F; Ermis SS; Inan UU Acta Ophthalmol Scand; 2007 Feb; 85(1):80-3. PubMed ID: 17244215 [TBL] [Abstract][Full Text] [Related]
6. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure. Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465 [TBL] [Abstract][Full Text] [Related]
8. Corneal thickness and glaucoma medications. Mehdizadeh M; Jamshidian-Tehrani M; Nowroozzadeh MH Ophthalmology; 2009 Jul; 116(7):1416-7; author reply 1417, 1417.e1. PubMed ID: 19576505 [No Abstract] [Full Text] [Related]
9. Safety and efficacy of bimatoprost 0.03% versus timolol maleate 0.5%/dorzolamide 2% fixed combination. Day DG; Sharpe ED; Beischel CJ; Jenkins JN; Stewart JA; Stewart WC Eur J Ophthalmol; 2005; 15(3):336-42. PubMed ID: 15945001 [TBL] [Abstract][Full Text] [Related]
10. A double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertension. Robin AL Eur J Ophthalmol; 2007; 17(4):685-6; author reply 686-7. PubMed ID: 17671954 [No Abstract] [Full Text] [Related]
12. A randomized trial assessing dorzolamide in patients with glaucoma who are younger than 6 years. Ott EZ; Mills MD; Arango S; Getson AJ; Assaid CA; Adamsons IA Arch Ophthalmol; 2005 Sep; 123(9):1177-86. PubMed ID: 16157797 [TBL] [Abstract][Full Text] [Related]
13. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study. Martínez A; Sánchez M Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468 [TBL] [Abstract][Full Text] [Related]
14. Modern alchemy: fixed combinations of glaucoma drugs. Katz LJ Am J Ophthalmol; 2005 Jul; 140(1):125-6. PubMed ID: 16038653 [No Abstract] [Full Text] [Related]
15. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma. Christiansen GA; Nau CB; McLaren JW; Johnson DH Ophthalmology; 2004 Sep; 111(9):1658-62. PubMed ID: 15350319 [TBL] [Abstract][Full Text] [Related]
16. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost. Tamer C; Oksüz H Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs. Plummer CE; MacKay EO; Gelatt KN Vet Ophthalmol; 2006; 9(4):245-9. PubMed ID: 16771760 [TBL] [Abstract][Full Text] [Related]
18. [Fixed combinations of glaucoma medications]. Călugăru D; Călugăru M Oftalmologia; 2008; 52(3):23-31. PubMed ID: 19149113 [TBL] [Abstract][Full Text] [Related]
19. Success rates for switching to dorzolamide/timolol fixed combination in timolol responders who are insufficiently controlled by latanoprost monotherapy. Sonty S; Henry JC; Sharpe ED; Weiss MJ; Stewart JA; Nelson LA; Stewart WC Acta Ophthalmol; 2008 Jun; 86(4):419-23. PubMed ID: 18039347 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure. Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]